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Abstract: The aim of this study was to evaluate the effectiveness of the combination of resistance
training (RT) and protein supplementation (PS), compared to RT alone or combined with a placebo
(plS), in the improvement of muscle strength and physical performance. The search strategy in
PubMed, Cochrane Library, and Web of Sciences databases found a total of 294 studies. Once inclusion
and exclusion criteria were applied, 16 studies were included for the qualitative analysis. A total
of 657 healthy elderly (>60 years) participants were analysed. Finally, 15 articles were included in
the quantitative analysis with one being excluded due to issues with data availability. Upper-limb,
lower-limb, and handgrip strength were the primary outcomes of the meta-analysis. The secondary
outcomes, related to physical performance, were Short Physical Performance Battery (SPPB), gait
speed, and the five-chair-rise test (5CRT). The main results of the meta-analysis show no statistical
differences for upper-limb (SMD: 0.56, 95% CI: −0.09, 1.21, p = 0.09, I2 = 68%), lower-limb (SMD:
0.00, 95% CI: −0.18, 0.18, p = 1.0, I2 = 11%), and handgrip strength (SMD: 0.03, 95% CI: −0.26,
0.32, p = 0.84, I2 = 0%) between the RT + PS and the RT alone (or combined with plS). Moreover,
no statistical differences were found relating to physical performance. In view of these results, protein
supplementation combined with RT does not provide additional benefits compared to RT alone or
with plS in healthy elderly adults.
Keywords: elderly; resistance training; protein supplementation; muscle strength; physical performance
1. Introduction
The ageing of the world’s population and the physical inactivity of older adults represent a major
public health problem [1]. Lower mortality and increasing lifespan have led to a diversification and
growth in chronic disease morbidity [2]. Such a trend includes an increased prevalence of aging-related
mobility impairments, even with aging in the absence of disease [3]. Moreover, only 27–44% of older
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U.S. adults meet the World Health Organization’s (WHO) general recommendations for physical
activity in adults [1,4]. In fact, individuals who did not meet this criteria have been found to have
double the risk of future limitations in functional capacity [5].
Traditionally, sarcopenia has been defined as the muscle mass decrease related to aging [6].
However, the European Working Group on Sarcopenia in Older People (EWGSOP) recently stated
that more attention should be given to a reduced muscle strength as the key characteristic to define
and identify sarcopenia, with reduced muscle mass and physical performance taken as secondary
factors [7]. Sarcopenia has an estimated prevalence of 10% in adults older than 60 years [3,8], rising
to 50% in adults older than 80 years [3,8]. Studies show that elderly patients with lower muscle
mass and strength have an increased probability of becoming dependent prematurely [9], longer and
more frequent hospitalizations [10], and mortality [11], which in turn translates into higher healthcare
costs [10].
Resistance training (RT) in the elderly population has been shown as the most useful tool for
avoiding sarcopenia [3,12,13]. Moreover, RT alone or combined with other training methodologies
has been demonstrated to be effective on the development of muscle mass, strength, and physical
performance, as well as a decreased risk of fall in the physically frail elderly population [3,14].
Additionally, total protein intake seems to play an important role in sarcopenia [15,16]. However,
protein supplementation (PS) alone has shown inconclusive results in its effectiveness to increase
muscle mass, strength, and physical performance in sarcopenic population [17,18]. Further studies
have shown positive effects of PS on muscle mass when combined with RT in older adults [19,20].
Given the importance of muscle strength and physical performance in the prevention and attenuation of
sarcopenia, it is important to analyse whether combined RT and PS protocols are effective in improving
these parameters [21].
The aim of this study is to evaluate if the combination of resistance training (RT) and protein
supplementation (PS) is more effective than resistance training alone or combined with placebo (plS) in
improving muscle strength and physical performance in healthy elderly adults.
2. Materials and Methods
2.1. Protocol and Registration
The study was performed following the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) statement checklist [22]. The systematic review and meta-analysis
protocol was registered in the Open Sciences Framework platform with the following DOI
number: 10.17605/OSF.IO/CMU4R.
2.2. Information Sources and Search
The PICO (Population, Intervention, Comparison, Outcomes) strategy was taken into account in
order to develop an accurate search strategy. The elected population was elderly people; the intervention
studied was resistance training (RT) combined with protein supplementation (PS); the comparison
chosen was resistance training alone or with placebo supplementation (plS); and the principal outcomes
were physical performance (PP) and strength (ST). The search strategy was combined with randomized
controlled trial (RCT) filters proposed by the Cochrane Collaboration [23]. The keywords used to
develop the search are shown and classified by the PICO strategy on Table 1.
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Table 1. Keywords used for the search strategy.
Population Intervention Control Outcomes
Aged Resistance training Protein supplementation Physical fitness























TUG: Timed Up and Go Test.
PubMed, Cochrane Library, and Web of Science were the databases used in this systematic review
and meta-analysis. Moreover, manual searches and lists of references from additional studies were
included, and other similar systematic reviews were checked in order to find potential studies that
might meet the inclusion criteria. The final search was performed on June 5th, 2020. Table 2 shows the
PubMed search strategy. The complete search strategies are available on the Supplementary S1.
Table 2. Search Strategy.
PubMed Search Strategy
(aged OR “old people” OR “older people” OR “older adults” OR “old adults” OR elderly OR senior OR
geriatric OR frail) AND (resistance training OR strength training) AND (“protein supplementation” OR
“supplemental protein”) AND (physical fitness OR functionality OR performance OR strength OR resistance
OR endurance OR balance OR stability OR agility OR mobility OR gait OR speed OR locomotion OR fall OR
handgrip OR SPPB OR tandem OR TUG OR “timed up and go” OR “quality of life”) AND ((randomized
controlled trial [pt] OR controlled clinical trial [pt] OR randomized [TiAb]) OR placebo [TiAb] OR clinical trials
as topic [mesh: noexp] OR randomly [TiAb]) OR trial [Ti]) NOT (animals [mh] NOT humans [mh]))
2.3. Eligibility Criteria and Study Selection
Studies were included if they met the following criteria: (1) randomized controlled trial (RCT)
study design, (2) adults aged >60, (3) healthy participants with or without sarcopenia condition,
(4) intervention group with resistance training combined with protein supplementation, (5) comparison
group with resistance training combined with placebo supplementation or no supplementation,
(6) physical performance or strength as outcome, and (7) English language.
Studies were excluded if (1) the sample comprised hospitalized or post-surgery participants,
(2) the sample comprised individuals with diabetes, cancer, cardiovascular disease, or other several
acute/chronic conditions, (3) participants were using other forms of supplementation, such as vitamins,
and (4) a resistance training duration of 8 weeks could not be completed.
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Two authors (NL and LLL) independently screened titles, abstracts, and full text for potential
inclusion. A third author (APB)was consulted in case of discrepancy. Inter-rater agreement was
assessed by using Cohen’s Kappa index [24].
2.4. Data Collection Process
For each study included in this systematic review, the following data was extracted: (1) author’s
last name, (2) year of publication, (3) sample size, (4) duration and frequency of the resistance training
protocol, (5) type and dosage of protein supplementation, (6) control group protocol, (7) outcomes,
and (8) main results.
2.5. Outcomes
The present systematic review and meta-analysis focused on two main outcomes: strength and
physical performance. The assessment of the strength capacity was focused on those tests with a goal
to determine the ability to generate high forces against large resistances. The assessment of physical
performance included other speed or agility tests with greater coordinative demands.
2.6. Risk of Bias of Individual Studies
The Risk of Bias 2 tool (RoB 2) [25] from the Cochrane Collaboration and Physiotherapy Evidence
Database (PEDro) scale [26] were used to assess the methodological quality and risk of bias of the
randomized controlled studies included on this systematic review and meta-analysis.
The Risk of Bias 2 tool [25] from the Cochrane Collaboration is a domain-based evaluation that
classifies seven domains from each randomized controlled trial into “low”, “unclear” or “high” risk of
bias. The seven domains are based on publication bias (sequence generation and allocation sequence
concealment), performance bias (blinding participants and personnel), detection bias (blinding outcome
assessor), attrition bias (incomplete data), reporting bias (selecting outcome reporting), and other bias
(e.g., sample size).
The PEDro scale [26] is an 11-item scale that relates the external validity (item 1), the internal
validity (items 2–9), and the applicability or generalizability (items 10–11). One point is awarded if the
criterion is clearly satisfied; thus, 11 points is the maximum score showing the highest methodological
quality of a randomized controlled trial.
2.7. Statistical Analyses
The present meta-analysis was carried out using the RevMan Manager 5.3 software (the Cochrane
Collaboration, London, UK, 2012). The sample size, means, and standard deviations (SD) for each
variable were introduced in the software. If necessary, SD was calculated by standard error or confidence
interval. All outcomes were continuous. If studies used different measuring tools, the chosen measure
of effect size was Standard Mean Difference (SMD). On the other hand, if studies used the same
measuring tool, Mean Difference (MD) was chosen as the effect size measure. An overall effect
size with a 95% interval confidence (CI) was calculated. When studies did not report specific data
(e.g., only graphs), an email was sent to the corresponding author asking for the missing data. If no
response was received, the study was removed from the meta-analysis.
The SMD or MD of each outcome was calculated using a random-effects model (DerSimonian-Laird
approach [27]). Heterogeneity across studies was evaluated by I2 statistics. Heterogeneity was classified
as “small”, “moderate”, or “high” if I2 was <25%, 25–75%, and >75%, respectively, as Higgins et al.
proposed [28]. The individual influence of each study on the overall result was analysed by removing
each study once. Funnel plot visual interpretation was performed for outcomes with more than
ten studies.
Nutrients 2020, 12, 2607 5 of 16
3. Results
3.1. Search Strategy
The search strategy found 294 studies (PubMed: 95; Cochrane Library: 105; Web of Science: 94).
An additional study was included after performing the manual search. A total of 128 studies were
excluded after checking and removing duplicates. A hundred and sixty-seven studies were initially
considered to be included.
3.2. Study Selection
Firstly, the titles and abstracts of all included studies were screened, and 144 were excluded after
this preliminary filter. Secondly, full text screening was carried out and 16 studies met the inclusion
criteria for the qualitative analysis. One study was removed from the meta-analysis for not presenting
the required data and after receiving no response from the corresponding author. Finally, 15 articles
were included in the quantitative synthesis. Analysis of Cohen’s Kappa index showed a k = 0.83
categorized as “almost perfect” agreement [24]. PRISMA flow chart with detailed study selection is
displayed in Figure 1.
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Table 3. Characteristics of the studies included in the qualitative analysis.
Study Population RT Intervention PS Intervention CG Outcomes MainResults




2019 [31] 28 (15/13) 14/14 12 w × 2 s/w
Whey
(+Leucine enriched) 20 g (+3 g)/s RT + plS PP ND PP
Arnarson,











RT + plS ST ↑ULSND LLS
Holwerda,
2018 [33] 40 (21/19) 40/0 12 w × 3 s/w
Whey




2019 [34] 21 (11/10) 12/9 12 w × 3 s/w Whey 0.165 g·kg
−1 RT + plS PP ND PP
Leenders,
2013 [35] 53 (27/26) 29/24 24 w × 3 s/w
Whey


















2016 [39] 25 (12/13) 11/14 24 w × 2 s/w Leucine 27.6 g/d RT + plS ST ND LLS
Sugihara,
2018 [40] 31 (15/16) 0/31 12 w × 3 s/w Whey 35 g/s RT + plS ST ↑ST
Tieland,












2009 [42] 26 (13/13) 26/0 12 w × 3 s/w Casein 20 g/s RT + plS ST ND LLS
Villanueva,
2014 [43] 14 (7/7) 14/0 12 w × 3 s/w
Whey





2015 [44] 53 (26/27) 53/0 12 w × 3 s/w Collagen peptides 15 g/d RT + plS ST ↑LLS
EG: Experimental Group; CG: Control Group; RT: Resistance Training; PS: Protein Supplementation; plS: Placebo
Supplementation; ND: No significant differences; ↑: Significant increase for EG; w: week; d: day; s: session;
ST: Strength; LLS: Lower-Limb Strength; ULS: Upper-Limb Strength; HS: Handgrip Strength; PP: Physical
Performance; SPPB: Short Physical Performance Battery, GS: Gait Speed, 5CRT: Five-Chair-Rise Test; TUG: Timed
Up and Go Test; NR: No Report.
Studies included in this systematic review involved participants from three continents. Two studies
were from Asia, two studies were carried out in North America, three in South America, and nine studies
in Europe.
Resistance training interventions had a duration of 12 weeks in most studies (n = 11) and the
most common frequency was 3 times/week (n = 11). Whey protein supplementation was the most
common across studies (n = 12). Fourteen studies assessed either lower-body or upper-body strength
and 11 studies assessed function outcomes.
The control group of 14 studies received the same resistance training program plus a placebo
supplementation. The remaining two studies had a control group receiving the same RT program
without placebo supplementation. Full additional characteristics of the sample and the resistance
training are available on Supplementary S2 and S3.
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3.4. Risk of Bias Assessment
The methodological quality assessment by PEDro scale revealed a high quality across studies
included in this systematic review. The average PEDro scale score was 8.5 points out of 11 (Table 4).
Table 4. PEDro scale.
Study 1 2 3 4 5 6 7 8 9 10 11 Total
Amasene, 2019 [31] X X X X X X X X 8
Arnarson, 2013 [30] X X X X X X X X X 9
Candow, 2008 [32] X X X X X X X X X 9
Holwerda, 2018 [33] X X X X X X X X X 9
Krause, 2019 [34] X X X X X X X X X 9
Leenders, 2013 [35] X X X X X X X X X 9
Mori, 2018 [36] X X X X X X X X 8
Nabuco, 2018 [37] X X X X X X X X X X 10
Nabuco, 2019 [38] X X X X X X X X X 9
Stragier S, 2016 [39] X X X X X 5
Sugihara, 2018 [40] X X X X X X X X X X 10
Tieland, 2012 [41] X X X X X X X X X X 10
Trabal, 2015 [29] X X X X X X X X 8
Verdijk, 2009 [42] X X X X X X X X 8
Villanueva, 2014 [43] X X X X X X X 7
Zdzieblik D, 2015 [44] X X X X X X X X X 9
Average 8.5
The RoB 2 tool summary and graph are shown in Figures 2 and 3. Nine studies (56%) had at least
four domains with “low risk”. Three studies (18%) had two or more domains as “high risk”.
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3.5.1. Lower-Limb Strength (LLS)
Fourteen studies provided data about changes in lower-extremity strength. Thirteen of them
assessed maximal quadriceps strength using a leg extension test (n = 12) or a leg press (n = 1).
Among the 13 studies, nine followed the 1-RM method, two used an isometric dynamometer and
two an isokinetic dynamometer. One study assessed the maximal voluntary contraction (MVC) of
the plantar flexor muscles using surface electromyography. These studies involve a total sample size
of 589 participants (298 in the protein supplementation + resistance training group and 291 in the
resistance training group).
The overall standard mean difference was 0.00 with a 95% confidence interval of [−0.18, 0.18]
and an overall effect of p = 1.0. The heterogeneity showed by the I2 statistic was low (I2 = 11%).
Figure 4 shows the forest plot for lower-limb strength. Visual interpretation of the funnel plot reveals
no evidence of publication bias for this outcome.
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3.5.2. Upper-Limb Strength (ULS)
Five studies provide data about changes in upper-extremity strength. The test used for this
variable was a chest/bench press test. All studies assessed the maximal strength using the 1-RM
method. A total of 66 participants were included in the intervention group (protein supplementation +
resistance training) and 71 participants were included in the control group (only resistance training).
The intervention and control groups did not differ in upper-limb strength with an overall standard
mean difference of 0.56 with a 95% confidence interval of [−0.09, 1.21] and an overall effect of p = 0.09.
The I2 statistic revealed a moderate heterogeneity across studies (68%) (Figure 5). To investigate this
factor, all studies were removed once from the analysis. When the Candow et al. [32] study was
removed, the heterogeneity was 0%.
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3.5.3. Handgrip Strength (HS)
Only four studies provided sufficient data about handgrip strength involving 93 participants for
the intervention group and 89 participants for the control group. The overall standard mean difference
was 0.03 with a 95% confidence interval [−0.26, 0.32] and an overall effect of p = 0.84. The heterogeneity
was I2 = 0% (Figure 6).
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3.5.4. Gait Speed (GS)
Five studies evaluated the physical performance by assessing participant’s gait speed.
The intervention group and control group sample sizes were 92 and 90 participants, respectively.
Two studies evaluated gait speed in meters per second. However, three studies assessed it as the
time taken to complete 10 m. Thus, the directionality of this data had to be opposed in the meta-analysis.
The overall standard mean difference was 0.11 with a 95% confidence interval [−0.18, 0.40] and an
overall effect of p = 0.45. The heterogeneity across studies was 0% based on I2 statistics (Figure 7).
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Three studies ere included in this o tco e analysis involving 119 articipants (62 i tervention
group and 57 control group). ll st ies se t e s e scale, s t e ifference as used as the
effect size measure.
The protein sup lementation plus resistance traini g group and resistance training group did not
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decreased to I2 = 0% (F gure 8).
Nutrients 2020, 12, x FOR PEER REVIEW 9 of 16 
 
difference was 0.03 with a 95% confidence interval [−0.26, 0.32] and an overall effect of p = 0.84. The 
heterogeneity was I2 = 0% (Figure 6). 
 
Figure 6. Impact of RT + PS on handgrip strength. 
3.5.4. Gait Speed (GS) 
Five studies evaluated the physical performance by assessing participant’s gait speed. The 
intervention group and control group sample sizes were 92 and 90 participants, respectively. 
Two studies evaluated gait speed in meters per second. However, three studies assessed it as the 
time taken to complete 10 m. Thus, the directionality of this data had to be opposed in the meta-analysis. 
The overall standard mean difference was 0.11 with a 95% confidence interval [−0.18, 0.40] and 
an overall effect of p = 0.45. The heterogeneity across studies was 0% based on I2 statistics (Figure 7). 
 
Figure 7. Impact of RT + PS on gait speed. 
3.5.5. Short Physical Performance Battery (SPPB) 
Three studies were included in this outcome analysis involving 119 participants (62 intervention 
group and 57 control group). All studies used the same scale, so the Mean Difference was used as the 
effect size measure. 
The protein supplementation plus resistance training group and resistance training group did 
not differ in terms of SPPB. The overall mean difference was 0.21 with a 95% confidence interval 
[−0.44, 0.85] and an overall effect of p = 0.53. Analysis by the I2 statistic revealed moderate 
heterogeneity (I2 = 50%). Removing the study from Amasene et al. [31] or the one from Holwerda et 
al. [33], the heterogeneity decreased to I2 = 0% (Figure 8). 
 
Figure 8. Impact of RT + PS on Short Physical Performance Battery (SPPB). 
3.5.6. Five-Chair-Rise Test (5CRT) 
Six studies measured physical performance by the five-chair-rise test. This analysis involved 108 
participants in the intervention group and 104 participants in the control group. Trabal et al. [29] only 
Figure 8. Impact of RT + PS on Short Physical Performance Battery (SPPB).
. . . i - i - i est (5 T)
i t i r physical performance by the five-chai -rise test. This analysis in olved
108 participants in the interve tion group and 104 participa ts in the c nt l group. Trab l et al. [29]
only provided data of the change from baseline, so higher values implied better results. However,
five studies measured it as the necessary time to achieve five chair rises with higher values implying
worse results. Therefore, the data directions of these studies needed to be opposed for the meta-analysis.
The overall standard mean difference was 0.16 with a 95% confidence interval [−0.12, 0.43] and
overall effect of p = 0.26. The heterogeneity across the studies was I2 = 0 (Figure 9).
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subgroup differences (p < 0.05). Forest plot with detailed information about this analysis are available
on the Supplementary S4.
Complete sensitivity analysis is also available in the Supplementary S5.
4. Discussion
The present article aims to summarize the effects of an RT intervention combined with PS compared
to an RT intervention alone or combined with placebo supplementation on strength and physical
performance in the healthy elderly population. This systematic review summarizes findings from a
total of 16 studies and including a total of 657 participants.
To our knowledge, this is the first meta-analysis that compares RT plus PS with RT alone or plus
placebo supplementation in a healthy elderly population. Notably, there are similar previous studies
that compared different populations, such as a younger population [45,46] or elderly hospitalized
people [47]; included a combination of other supplements, such as vitamin 3, omega-3, or a dietary
intake modification [19,48–51]; or studied other outcomes related to body composition [52,53].
In view of the results, our meta-analysis shows no statistical differences between RT in combination
with PS compared with RT alone or combined with placebo on upper- and lower-limb strength, handgrip
strength, gait speed, and functional tests SPPB and 5CRT.
4.1. Muscle Strength
Handgrip strength is a simple and inexpensive way to assess muscle strength [54], and it has been
established as a reliable tool to predict increased functional limitations, quality of life, and death [55,56].
Moreover, handgrip strength has a moderate correlation with the strength of other parts of the body [7].
In fact, chest and leg press exercises are also used for the assessment of muscle strength in the elderly
population [57].
Our findings suggest that protein supplementation does not provide any greater benefit when
compared to RT alone or combined with placebo in terms of muscle strength improvements in both
lower and upper limbs and handgrip strength in healthy elderly adults. These results agree with
previous meta-analyses conducted by Ten Haaf et al. [47], Finger et al. [49], and Morton et al. [51],
but differ from those of Hou et al. [46] and Liao et al. [19].
We believe that the difference between our findings and these studies lies in that Hou et al. [46]
and Liao et al. [19] included other supplements, such as vitamin D, and their study populations were
aged >50 years [46] or included hospitalized people [19]. In that sense, it could be hypothesized that
PS might only provide additional benefits to RT in frail people, who are characterised by greater losses
of muscle mass which may limit muscle strength development.
It is important to note that heterogeneity across studies was low for lower-limb strength (I2 = 11%)
and handgrip strength (I2 = 0%), but moderate for upper-limb strength (I2 = 68%). Heterogeneity
for upper-limb strength could be explained by the study of Candow et al. [32]. The heterogeneity
was 0% when it was removed. The study design proposed by Candow et al. [32] is the only one
including a ST program shorter than 12 weeks, which is the duration recommended by the National
Strength and Conditioning Association (NSCA) [3]. This study notably favors RT + PS with a standard
mean difference [95% CI] of 2.41 [1.26, 3.55]. It is difficult to provide with consistent evidence-based
explanations given the large heterogeneity of the results. It could be possible that the effects of the
PS on upper-limb muscle strength appear in a shorter term (<12 weeks) and favor the combination
RT + PS. However, as the other included studies have a longer duration (>12 weeks), the effects of the
PS might be underestimated.
4.2. Physical Performance
Apart from strength, physical performance assesses the whole-body function related to locomotion
and the individual’s health status [7,13]. Some of the most relevant functional tests are SPPB [58,59],
gait speed [60–62], and 5CRT [63,64].
Nutrients 2020, 12, 2607 12 of 16
As suggested by a previous meta-analysis conducted by Ten Haaf et al. [47] and Hou et al. [46],
our results also show that PS combined with RT is not more effective than RT alone or combined
with placebo in developing physical performance improvement in healthy elderly adults. In contrast,
when studying a frailer population (hospitalized, institutionalized, or community-dwelling elderly
individuals with a high risk of sarcopenia or frailty and physical limitations), the results from
Liao et al. [19] showed significant improvements in the RT + PS group. These findings suggest that
frail people who have some physical impairments could benefit from protein supplementation, but not
in the case of healthy people with no severe physical limitations.
4.3. Protein Supplementation
Current recommendations for daily protein intake range from 1.2 to 1.5 g/kg body weight/day
for elderly active population [65,66]. These amounts can be achieved through diet or through
protein supplementation. To date, there is no general recommendation on the appropriate protein
supplementation dose, since it depends on the body composition of each individual, as well as on their
physical fitness and health conditions. However, some studies indicate that the dose could be between
25 and 30 g of protein [67]. Following these data, in at least eight of the studies included in this review,
the supplementation dose is less than 25 g, so its benefits may not be reflected.
In general, our findings support the idea that resistance training is one of the most effective
strategies to prevent or delay frailty condition in an elderly population.
Finally, the absence of additional benefits of PS when combined to RT suggests that we should
rethink if it is necessary to supplement with protein every elderly people without taking into account
their fitness or their health status.
This meta-analysis has some limitations, mainly related to the heterogeneous characteristics
(intensity, frequency, volume etc.) and duration of the resistance training programs, the different types
and doses of protein intake, and the diversity of the methods used to assess muscle strength and
physical performance. Moreover, a longer follow-up may have been interesting to analyse if differences
are seen in the long term.
5. Conclusions
In view of our results, there is not sufficient evidence to support the use of protein supplementation
when combined with resistance training in healthy elderly adults for improving muscle strength
and physical performance. Protein supplementation combined with RT does not provide additional
benefits compared to RT alone. Future primary studies are needed to analyse the different protocols of
protein supplementation. Furthermore, studies with longer follow-up periods should be conducted in
order to analyse possible differences over time
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/12/9/2607/s1,
Supplementary S1: Complete literature search, Supplementary S2: Additional characteristics of the resistance
training protocols, Supplementary S3: Additional sample characteristics, Supplementary S4: Subgroup Analysis by
Sarcopenia Condition, Supplementary S5: Complete sensitivity Analysis evaluating heterogeneity across studies.
Author Contributions: All review authors (N.L.-L., L.L.-A., C.L.-d.-C., J.R.-S., V.G.-R., C.H.-G., B.M.-P. and A.P.-B.)
contributed to the development of the review. N.L.-L., L.L.-A. and A.P.-B. selected the final included studies and
extracted data. N.L.-L. and L.L.-A. entered data into RevMan and carried out the meta-analysis. N.L.-L. and
L.L.-A. interpreted the results. N.L.-L., L.L.-A. and J.R.-S. wrote the article. C.L.-d.-C., V.G.-R., C.H.-G., B.M.-P.
and A.P.-B. reviewed and verified the paper. As the contact author, A.P.B. has overall responsibility for the review.
All authors have read and agreed to the published version of the manuscript.
Funding: This research received no external funding.
Acknowledgments: We would like to acknowledge Alexandra M. Myers for the English language revision.
Also, would like to thank the authors of the included studies for helping us with the required missing data.
Conflicts of Interest: The authors declare no conflict of interest.
Nutrients 2020, 12, 2607 13 of 16
References
1. García-Hermoso, A.; Ramirez-Vélez, R.; Sáez De Asteasu, M.L.; Martínez-Velilla, N.; Zambom-Ferraresi, F.;
Valenzuela, P.L.; Lucia, A.; Izquierdo, M. Safety and Effectiveness of Long-Term Exercise Interventions in
Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Sports Med. 2020,
50, 1095–1106. [CrossRef] [PubMed]
2. Beltrán-Sánchez, H.; Jiménez, M.P.; Subramanian, S.V. Assessing morbidity compression in two cohorts from
the health and retirement study. J. Epidemiol. Community Health 2016, 70, 1011–1016. [CrossRef]
3. Fragala, M.S.; Cadore, E.L.; Dorgo, S.; Izquierdo, M.; Kraemer, W.J.; Peterson, M.D.; Ryan, E.D. Resistance
Training for Older Adults: Position Statement From the National Strength and Conditioning Association.
J. Strength Cond. Res. 2019, 33, 2019–2052. [CrossRef] [PubMed]
4. Keadle, S.K.; McKinnon, R.; Graubard, B.I.; Troiano, R.P. Prevalence and trends in physical activity among
older adults in the United States: A comparison across three national surveys. Prev. Med. (Baltim.) 2016, 89,
37–43. [CrossRef]
5. Visser, M.; Simonsick, E.M.; Colbert, L.H.; Brach, J.; Rubin, S.M.; Kritchevsky, S.B.; Newman, A.B.; Harris, T.B.
Type and intensity of activity and risk of mobility limitation: The mediating role of muscle parameters. J. Am.
Geriatr. Soc. 2005, 53, 762–770. [CrossRef] [PubMed]
6. Cruz-Jentoft, A.J.; Baeyens, J.P.; Bauer, J.M.; Boirie, Y.; Cederholm, T.; Landi, F.; Martin, F.C.; Michel, J.P.;
Rolland, Y.; Schneider, S.M.; et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing
2010, 39, 412–423. [CrossRef] [PubMed]
7. Cruz-Jentoft, A.J.; Bahat, G.; Bauer, J.; Boirie, Y.; Bruyère, O.; Cederholm, T.; Cooper, C.; Landi, F.; Rolland, Y.;
Sayer, A.A.; et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019, 48,
16–31. [CrossRef] [PubMed]
8. Shafiee, G.; Keshtkar, A.; Soltani, A.; Ahadi, Z.; Larijani, B.; Heshmat, R. Prevalence of sarcopenia in the
world: A systematic review and meta- analysis of general population studies. J. Diabetes Metab. Disord. 2017,
16, 1–10. [CrossRef]
9. Dos Santos, L.; Cyrino, E.S.; Antunes, M.; Santos, D.A.; Sardinha, L.B. Sarcopenia and physical independence
in older adults: The independent and synergic role of muscle mass and muscle function. J. Cachexia
Sarcopenia Muscle 2017, 8, 245–250. [CrossRef]
10. Gani, F.; Buettner, S.; Margonis, G.A.; Sasaki, K.; Wagner, D.; Kim, Y.; Hundt, J.; Kamel, I.R.; Pawlik, T.M.
Sarcopenia predicts costs among patients undergoing major abdominal operations. Surgery (United States)
2016, 160, 1162–1171. [CrossRef]
11. Landi, F.; Cruz-Jentoft, A.J.; Liperoti, R.; Russo, A.; Giovannini, S.; Tosato, M.; Capoluongo, E.; Bernabei, R.;
Onder, G. Sarcopenia and mortality risk in frail olderpersons aged 80 years and older: Results from
iLSIRENTE study. Age Ageing 2013, 42, 203–209. [CrossRef]
12. Clark, C.; Manini, T. Sarcopenia , Dynapenia | The Journals of Gerontology: Series A | Oxford Academic.
J. Gerontol. 2008, 63, 829–834. [CrossRef] [PubMed]
13. Valenzuela, P.L.; Morales, J.S.; Pareja-Galeano, H.; Izquierdo, M.; Emanuele, E.; de la Villa, P.; Lucia, A.
Physical strategies to prevent disuse-induced functional decline in the elderly. Ageing Res. Rev. 2018, 47,
80–88. [CrossRef]
14. Lopez, P.; Pinto, R.S.; Radaelli, R.; Rech, A.; Grazioli, R.; Izquierdo, M.; Cadore, E.L. Benefits of resistance
training in physically frail elderly: A systematic review. Aging Clin. Exp. Res. 2018, 30, 889–899. [CrossRef]
[PubMed]
15. Marzetti, E.; Calvani, R.; Tosato, M.; Cesari, M.; Di Bari, M.; Cherubini, A.; Collamati, A.; D’Angelo, E.;
Pahor, M.; Bernabei, R.; et al. Sarcopenia: An overview. Aging Clin. Exp. Res. 2017, 29, 11–17. [CrossRef]
[PubMed]
16. Cruz-Jentoft, A.J.; Kiesswetter, E.; Drey, M.; Sieber, C.C. Nutrition, frailty, and sarcopenia. Aging Clin.
Exp. Res. 2017, 29, 43–48. [CrossRef] [PubMed]
17. Tessier, A.J.; Chevalier, S. An update on protein, leucine, omega-3 fatty acids, and vitamin d in the prevention
and treatment of sarcopenia and functional decline. Nutrients 2018, 10, 1099. [CrossRef]
18. Martone, A.M.; Marzetti, E.; Calvani, R.; Picca, A.; Tosato, M.; Santoro, L.; Di Giorgio, A.; Nesci, A.;
Sisto, A.; Santoliquido, A.; et al. Exercise and Protein Intake: A Synergistic Approach against Sarcopenia.
BioMed Res. Int. 2017, 2017, 2672435. [CrossRef]
Nutrients 2020, 12, 2607 14 of 16
19. Liao, C.-D.; Chen, H.-C.; Huang, S.-W.; Liou, T.-H. The Role of Muscle Mass Gain Following Protein
Supplementation Plus Exercise Therapy in Older Adults with Sarcopenia and Frailty Risks: A Systematic
Review and Meta-Regression Analysis of Randomized Trials. Nutrients 2019, 11, 1713. [CrossRef]
20. Shad, B.J.; Thompson, J.L.; Breen, L. Does the muscle protein synthetic response to exercise and amino
acid-based nutrition diminish with advancing age? a systematic review. Am. J. Physiol.-Endocrinol. Metab.
2016, 311, E803–E817. [CrossRef]
21. Paddon-Jones, D.; Short, K.R.; Campbell, W.W.; Volpi, E.; Wolfe, R.R. Role of dietary protein in the sarcopenia
of aging. Am. J. Clin. Nutr. 2008, 87, 1562–1566. [CrossRef] [PubMed]
22. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; Altman, D.; Antes, G.; Atkins, D.; Barbour, V.; Barrowman, N.;
Berlin, J.A.; et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement.
PLoS Med. 2009, 6, e1000097. [CrossRef]
23. Higgins, J.P.T.; Thomas, J.; Chandler, J.; Cumpston, M.; Li, T.; Page, M.J.; Welch, V.A. (Eds.) Cochrane Handbook
for Systematic Reviews of Interventions; Wiley: Chichester, UK, 2019; ISBN 9781119536628.
24. Landis, J.R.; Koch, G.G. The Measurement of Observer Agreement for Categorical Data. Biometrics 1977,
33, 159. [CrossRef]
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